Lineage Cell Therapeutics In shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $87k | 175k | 0.50 |
| 2024-09-30 | $54k | 59k | 0.91 |
| 2024-06-30 | $58k | 58k | 1.00 |
| 2024-03-31 | $111k | 75k | 1.48 |
| 2023-12-31 | $83k | 76k | 1.09 |
| 2023-09-30 | $93k | 79k | 1.18 |
| 2023-06-30 | $15k | 11k | 1.41 |
| 2022-03-31 | $105k | 68k | 1.54 |
| 2021-12-31 | $187k | 76k | 2.46 |
| 2021-09-30 | $182k | 72k | 2.52 |
| 2021-06-30 | $205k | 72k | 2.85 |
| 2020-03-31 | $28k | 34k | 0.83 |
| 2019-12-31 | $31k | 36k | 0.86 |
| 2019-09-30 | $27k | 29k | 0.96 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft